Medifast, Inc. (MED) Insider Trading Activity

NYSE$13.06+0.47 (3.73%)
Market Cap
$140.79M
Sector
Consumer Cyclical
Industry
Personal Products & Services
Rank in Sector
42 of 399
Rank in Industry
1 of 9

MED Insider Trading Activity

MED Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,733,504
8
80
Sells
$226,289
2
20

Related Transactions

Kiai Parsadirector
5
$1.49M
0
$0
$1.49M
Chard Daniel RChairman & CEO
1
$178,725
2
$226,289
$-47,564
SCHLACKMAN SCOTTdirector
2
$62,950
0
$0
$62,950

About Medifast, Inc.

Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by …

Insider Activity of Medifast, Inc.

Over the last 12 months, insiders at Medifast, Inc. have bought $1.73M and sold $226,289 worth of Medifast, Inc. stock.

On average, over the past 5 years, insiders at Medifast, Inc. have bought $769,516 and sold $1.18M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kiai Parsa (director) — $1.49M. Chard Daniel R (Chairman & CEO) — $178,725. SCHLACKMAN SCOTT (director) — $62,950.

The last purchase of 5,557 shares for transaction amount of $68,027 was made by Kiai Parsa (director) on 2026‑10‑28.

List of Insider Buy and Sell Transactions, Medifast, Inc.

2026-10-28PurchaseKiai Parsadirector
5,557
0.0495%
$12.24
$68,027
+0.94%
2026-09-29SaleChard Daniel Rdirector
9,544
0.0867%
$11.73
$111,951
+2.33%
2026-09-28SaleChard Daniel Rdirector
9,545
0.0877%
$11.98
$114,338
+1.41%
2026-08-26PurchaseKiai Parsadirector
43,150
0.3894%
$12.26
$529,157
-1.43%
2026-08-24PurchaseKiai Parsadirector
4,329
0.0389%
$12.00
$51,946
+0.46%
2026-08-20PurchaseKiai Parsadirector
43,150
0.3875%
$11.60
$500,700
+3.66%
2026-08-19PurchaseKiai Parsadirector
29,337
0.2656%
$11.66
$341,999
+3.97%
2026-05-11PurchaseSCHLACKMAN SCOTTdirector
2,500
0.0227%
$12.53
$31,325
-3.67%
2026-05-08PurchaseSCHLACKMAN SCOTTdirector
2,500
0.0226%
$12.65
$31,625
-5.08%
2026-03-20PurchaseChard Daniel RChairman & CEO
17,678
0.1626%
$10.11
$178,725
+16.50%
2025-06-13PurchaseChard Daniel RChairman & CEO
381
0.0035%
$13.13
$5,003
-7.09%
2024-03-08SaleSCHLACKMAN SCOTTdirector
4,053
0.0367%
$39.44
$159,866
-51.71%
2023-11-07PurchaseSCHLACKMAN SCOTTdirector
52.65
0.0005%
$68.89
$3,627
-62.82%
2023-11-07PurchaseHoer Michael A.director
49.76
0.0005%
$68.89
$3,428
-62.82%
2023-11-07PurchaseThomas Andrea Bdirector
50.39
0.0005%
$68.89
$3,471
-62.82%
2023-11-07PurchaseBROWN JEFFREY Jdirector
58.35
0.0005%
$68.89
$4,020
-62.82%
2023-11-07PurchaseXian Mingdirector
48.44
–
$0
$0
-62.82%
2023-11-03PurchaseBROWN JEFFREY Jdirector
96.74
0.0009%
$70.55
$6,825
-62.79%
2023-10-06SaleHALLQUIST CONSTANCE J.
5,613
0.0515%
$73.87
$414,632
-54.25%
2023-08-15SaleBROWN JEFFREY Jdirector
23,162
0.215%
$90.18
$2.09M
-41.25%
Total: 214
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Kiai Parsadirector
712891
6.375%
$8.98M50
Chard Daniel Rdirector
130609
1.168%
$1.64M57
<0.0001%
SCHLACKMAN SCOTTdirector
30549
0.2732%
$384,608.2276
<0.0001%
MACDONALD BRADLEY TExec. Chairman of the Board
579521
5.1823%
$7.3M25
<0.0001%
MACDONALD MICHAEL Cdirector
266179
2.3803%
$3.35M18
<0.0001%
ZION SCOTTAssistant Secretary
185000
1.6544%
$2.33M14
<0.0001%
Welling Glenn W.director
22380
0.2001%
$281,764.2062
+22.99%
TRAVIS MARY T
12583
0.1125%
$158,419.9712
<0.0001%
Hoer Michael A.director
8375
0.0749%
$105,447.2160
<0.0001%
Thomas Andrea Bdirector
6253
0.0559%
$78,726.8251
<0.0001%
BROWN JEFFREY Jdirector
5784
0.0517%
$72,816.12322
<0.0001%
Xian Mingdirector
4813
0.043%
$60,594.6430
HALLQUIST CONSTANCE J.
2152
0.0192%
$27,093.6836
<0.0001%
KELLEMAN JOSEPH PVice President of Finance
2000
0.0179%
$25,180.0011
+22.57%
HALLOCK ROBERT JCorporate Vice President
1000
0.0089%
$12,590.0010
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$61,778,404
64
6.82%
$129.78M
$14,963
5
-33.34%
$5.25M

MED Institutional Investors: Active Positions

Increased Positions38+22.35%731,328+7.93%
Decreased Positions73-42.94%2M-20.51%
New Positions13New356,840New
Sold Out Positions27Sold Out265,966Sold Out
Total Postitions135-20.59%8M-12.59%

MED Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$9,549.008.35%918,148+18,964+2.11%2025-09-30
Renaissance Technologies Llc$8,329.007.28%800,910-12,400-1.52%2025-09-30
Vanguard Group Inc$7,398.006.47%711,309-104,737-12.84%2025-09-30
Charles Schwab Investment Management Inc$6,190.005.41%595,211+174,042+41.32%2025-09-30
Morgan Stanley$6,121.005.35%588,539+130,753+28.56%2025-09-30
Bank Of America Corp /De/$4,706.004.11%452,543+56,174+14.17%2025-09-30
Acadian Asset Management Llc$4,133.003.61%397,442-13,659-3.32%2025-09-30
Lido Advisors, Llc$3,439.003.01%330,703+330,703New2025-09-30
Aqr Capital Management Llc$3,233.002.83%310,819+90,688+41.2%2025-09-30
Dimensional Fund Advisors Lp$3,103.002.71%298,369+48,967+19.63%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.